Taipei Exchange - Delayed Quote TWD

TSH Biopharm Corporation Limited (8432.TWO)

Compare
57.60
-1.60
(-2.70%)
At close: 1:30:14 PM GMT+8

Key Executives

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Ms. Sze-Yuan Yang General Manager 5.72M -- --
Mr. Xin-Yang Liu Vice General Manager of General Administration 3.06M -- --
Mr. Jung-Liang Kao Chief Financial Officer -- -- --
Ms. Chen-Ju Kan Senior Manager of the Accounting Department -- -- --
Mr. Jian-Rong Huang Sales Division Director -- -- --
Mr. Hsin-Young Liu Company Secretary -- -- --

TSH Biopharm Corporation Limited

No. 3-1, Park Street
3rd Floor-1 Nangang District
Taipei, 11503
Taiwan
886 2 2655 8525 https://www.tshbiopharm.com
Sector: 
Healthcare

Description

TSH Biopharm Corporation Limited develops and markets pharmaceutical products in Taiwan and Asia. It offers products for cardiovascular, central nervous, gastrointestinal, and others. The company was founded in 1999 and is headquartered in Taipei city, Taiwan. TSH Biopharm Corporation Limited is a subsidiary of TTY Biopharm Company Limited.

Corporate Governance

TSH Biopharm Corporation Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

June 17, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers